Vault-13

INOZYME PHARMA INC

COM · CUSIP 45790W108

0 institutional holders -88 vs Q2 2025
—reported value*
0 new 0 added 0 reduced 85 sold out net sold ≈ $188.0m (-47.0m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q3 2025

Institutional holders

Managers reporting a position, each quarter

050100150Q3 22: 39Q4 22: 38Q1 23: 51Q2 23: 75Q3 23: 78Q4 23: 81Q1 24: 90Q2 24: 91Q3 24: 90Q4 24: 106Q1 25: 98Q2 25: 88Q3 25: 00Q3 22Q2 23Q1 24Q4 24Q3 25
Numbers
QuarterHolders
Q3 202239
Q4 202238
Q1 202351
Q2 202375
Q3 202378
Q4 202381
Q1 202490
Q2 202491
Q3 202490
Q4 2024106
Q1 202598
Q2 202588
Q3 20250

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
1000100Q4 23: 54 bought or addedQ4 23: 24 cut or sold outQ1 24: 41 bought or addedQ1 24: 41 cut or sold outQ1 24Q2 24: 56 bought or addedQ2 24: 39 cut or sold outQ3 24: 45 bought or addedQ3 24: 32 cut or sold outQ3 24Q4 24: 61 bought or addedQ4 24: 36 cut or sold outQ1 25: 42 bought or addedQ1 25: 46 cut or sold outQ1 25Q2 25: 42 bought or addedQ2 25: 75 cut or sold outQ3 25: 0 bought or addedQ3 25: 85 cut or sold outQ3 25
Numbers
QuarterBought or addedCut or sold out
Q4 20235424
Q1 20244141
Q2 20245639
Q3 20244532
Q4 20246136
Q1 20254246
Q2 20254275
Q3 2025085

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$250k$500k$750k$1mQ4 24 calls: $7.2kQ4 24 puts: $15.1kQ4 24P/C 2.10Q1 25 calls: $12.6kQ1 25 puts: $910Q1 25P/C 0.07Q2 25 calls: $826.8kQ2 25 puts: $0Q2 25P/C 0.00Q3 25 calls: $0Q3 25 puts: $0Q3 25P/C —
Numbers
QuarterCallsPutsP/C
Q4 2024$7.2k$15.1k2.10
Q1 2025$12.6k$9100.07
Q2 2025$826.8k$00.00
Q3 2025$0$0—

Biggest buyers

None

Biggest sellers

Beryl Capital Management LLC Sold out -6,321,584-6.3m
Pivotal bioVenture Partners Investment Advisor LLC Sold out -4,494,851-4.5m
GLAZER CAPITAL, LLC Sold out -4,330,220-4.3m
Sofinnova Investments, Inc. Sold out -4,280,308-4.3m
Trium Capital LLP Sold out -3,173,454-3.2m
BlackRock, Inc. Sold out -2,663,678-2.7m
VANGUARD GROUP INC Sold out -2,498,649-2.5m
NEA Management Company, LLC Sold out -2,437,689-2.4m
ALPINE ASSOCIATES MANAGEMENT INC. Sold out -2,188,100-2.2m
Affinity Asset Advisors, LLC Sold out -1,749,359-1.7m

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
GLAZER CAPITAL, LLC 13G · passive investor new · filed 2025-06-04 6.6% new 4.3m 2025-06-04

Holders, Q3 2025

#ManagerLocationShares Value% of their portfolioChangeShares change